Latest total current liabilities for SILO: $700K.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (March 2026), SILO shows a total current liabilities of $700K. That compares with $1.2M in the prior-year period — down 40.5% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, SILO's total current liabilities is now $700K (was $1.2M) — a 40.5% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether SILO Pharma is outperforming or lagging.
Tracking SILO's total current liabilities over time shows whether SILO Pharma is scaling, shrinking, or reshaping that part of the business. The current reading is $700K That compares with $1.2M in the prior-year period — down 40.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this total current liabilities page, Stockcircle has SILO Pharma's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total current liabilities (currently $700K) with ownership activity and broader fundamentals.
SILO Pharma's total current liabilities is $700K; compare it with other Finance names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.